IQVIA Holdingsvs.West Pharmaceutical Services
IQV vs WST · both in CDMO & pharma manufacturing, part of the Medicine, pharma & life science value chain: Contract development and manufacturing of medicines — the industrial backbone behind the drugs.
IQVIA Holdings is about 1.4× larger than West Pharmaceutical Services by market cap; IQVIA Holdings trades at the lower P/E (25.0 vs 46.1); year to date, West Pharmaceutical Services leads (+28.6% vs −7.8%).
Side by side
| IQV | WST | |
|---|---|---|
| Market cap | $34.6B | $25B |
| Price | $207.85 | $353.71 |
| Today | −0.5% | −1.1% |
| Return YTD | −7.8% | +28.6% |
| Return 1Y | +25.6% | +54.3% |
| P/E | 25.0 | 46.1 |
| P/S | 2.1 | 7.8 |
| P/B | 5.6 | 8.4 |
Data as of 2026-07-11 · updates daily after U.S. close
The two companies
IQVIA HoldingsIQV
Clinical research (CRO) and healthcare data analytics for the pharmaceutical industry.
Full IQV profile →West Pharmaceutical ServicesWST
American manufacturer of packaging and injection systems for pharmaceuticals — stoppers, syringe components and delivery systems, including for injectable biologics.
Full WST profile →More comparisons in CDMO & pharma manufacturing
See where IQV and WST sit in the full Medicine, pharma & life science map — every segment from suppliers to end markets.Open the Life science value chain →